Facing a 40% mortality rate in candidemia patients, drug-resistant Candida and their petite
mutants remain a major treatment challenge. Antimicrobial photodynamic therapy (aPDT) …

Background Candida spp. are recognized as a primary agent of severe fungal infection in
immunocompromised patients, and are the fourth most common cause of bloodstream …

Invasive Candida albicans infection is a significant opportunistic fungal infection in humans
because it is one of the most common colonizers of the gut, mouth, vagina, and skin. Despite …

Cutaneous and mucocutaneous Candida infections are considered to be important targets
for antimicrobial photodynamic therapy (PDT). Clinical application of antimicrobial PDT will …

Abstract Introduction. The advent of Candida ssp. strains that are resistant to different drugs,
or MDR strains, highlights the necessity of creating novel antimycotics that are both effective …

Fungal infections are increasing in prevalence worldwide, especially in
immunocompromised individuals. Given the emergence of drug-resistant fungi and the fact …

Human candidiasis is typically treated with antifungal drugs, but the rise of drug-resistant
strains of Candida spp. poses a serious problem, making treatment difficult. At the same …

The effectiveness of antimicrobial photodynamic therapy (aPDT) in the treatment of oral
yeast infections was examined many times in recent years. The authors of this review tried to …

Background Antimicrobial photodynamic therapy (aPDT) efficiency on Candida albicans is
recognized in free-floating cultures. Though, the lack of aPDT effectiveness against C …

Antimicrobial Photodynamic Therapy (aPDT) has been extensively investigated in vitro, and
preclinical animal models of infections are suitable for evaluating alternative treatments prior …